全文获取类型
收费全文 | 99421篇 |
免费 | 11334篇 |
国内免费 | 7241篇 |
专业分类
耳鼻咽喉 | 1036篇 |
儿科学 | 995篇 |
妇产科学 | 750篇 |
基础医学 | 9672篇 |
口腔科学 | 2120篇 |
临床医学 | 12744篇 |
内科学 | 12048篇 |
皮肤病学 | 1108篇 |
神经病学 | 4140篇 |
特种医学 | 4021篇 |
外国民族医学 | 39篇 |
外科学 | 11054篇 |
综合类 | 21727篇 |
现状与发展 | 34篇 |
一般理论 | 8篇 |
预防医学 | 8399篇 |
眼科学 | 2321篇 |
药学 | 11168篇 |
137篇 | |
中国医学 | 7365篇 |
肿瘤学 | 7110篇 |
出版年
2024年 | 498篇 |
2023年 | 1875篇 |
2022年 | 4794篇 |
2021年 | 5967篇 |
2020年 | 4852篇 |
2019年 | 3520篇 |
2018年 | 3559篇 |
2017年 | 3739篇 |
2016年 | 3307篇 |
2015年 | 5122篇 |
2014年 | 6235篇 |
2013年 | 6351篇 |
2012年 | 9094篇 |
2011年 | 9630篇 |
2010年 | 7088篇 |
2009年 | 5857篇 |
2008年 | 6469篇 |
2007年 | 5908篇 |
2006年 | 5224篇 |
2005年 | 4466篇 |
2004年 | 2905篇 |
2003年 | 2368篇 |
2002年 | 1874篇 |
2001年 | 1440篇 |
2000年 | 1314篇 |
1999年 | 1097篇 |
1998年 | 561篇 |
1997年 | 529篇 |
1996年 | 441篇 |
1995年 | 378篇 |
1994年 | 296篇 |
1993年 | 188篇 |
1992年 | 183篇 |
1991年 | 163篇 |
1990年 | 162篇 |
1989年 | 116篇 |
1988年 | 101篇 |
1987年 | 77篇 |
1986年 | 62篇 |
1985年 | 36篇 |
1984年 | 24篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1979年 | 11篇 |
1978年 | 15篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1972年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的探讨脊髓小脑共济失调2型(SCA2)致病基因ATXN2异常等位基因中间重复个体的表型和分子遗传学特点。方法针对2005—2018年中日友好医院神经科运动障碍与神经遗传病研究中心收集的1383个常染色体显性遗传共济失调家系的先证者和部分家系成员,采用荧光标记毛细管电泳片段分析方法进行动态突变检测,对携带ATXN2基因中间重复的个体进行临床表型和遗传特征分析。结果共检出163个家系(包含先证者和家系成员共203人)携带异常扩展的ATXN2基因CAG重复序列,其中93个家系中有107例的异常扩展等位基因重复次数在29~34次之间。在其中的20个亲子对中,父系遗传16个,异常等位基因的代间扩展增加0~28次,母系遗传4个,异常等位基因的代间扩展增加0~4次。结论对于临床拟诊SCA2家系患者,需对其亲代或成年子代个体进行ATXN2基因检测,以免漏诊。动态突变基因检测有助于识别中间重复的个体,对明确家系致病基因和遗传咨询至关重要。 相似文献
3.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
5.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
6.
目前临床研究已证实腹腔镜胃癌根治术治疗早期胃癌的安全性、可行性和有效性。基于此,第4版日本《胃癌治疗指南》推荐腹腔镜手术治疗临床Ⅰ期远端胃癌。然而,腹腔镜胃癌手术治疗进展期胃癌的有效性和安全性仍存争议。中国腹腔镜胃肠外科研究组(CLASS研究组)发起的CLASS-01研究顺利完成,提供了全球首个局部进展期胃癌腹腔镜手术安全性和疗效的前瞻性多中心证据。胃癌外科的主流方向在从“大切口和扩大化手术切除”逐渐向“微创、精准化手术”转变,以使手术安全性和病人术后生活质量最优化。 相似文献
7.
8.
9.
10.